Imvt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Imvt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Imvt Today - Breaking & Trending Today

FY2024 EPS Estimates for Immunovant, Inc. Lifted by Zacks Research (NASDAQ:IMVT)

Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Stock analysts at Zacks Research increased their FY2024 earnings estimates for shares of Immunovant in a research note issued on Thursday, April 25th. Zacks Research analyst E. Bagri now expects that the company will post earnings of ($1.72) per share for the year, up from their prior forecast […] ....

New Zealand General , New Zealand , Juliag Butchko , Eva Renee Barnett , Zacks Research , Allspring Global Investments Holdings , Goldman Sachs Group , Citigroup Inc , Immunovant Inc , Wolfe Research , Wellington Management Group , Cantor Fitzgerald , Investment Company Inc , Securities Exchange Commission , Investment Management , Jpmorgan Chase Co , Free Report , Get Free Report , Global Investments Holdings , Management Group , Renee Barnett , Exchange Commission , Immunovant Daily , Nasdaq Imvt , Earnings Estimates ,

Julia G. Butchko Sells 10,115 Shares of Immunovant, Inc. (NASDAQ:IMVT) Stock

Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) insider Julia G. Butchko sold 10,115 shares of the business’s stock in a transaction dated Wednesday, April 17th. The shares were sold at an average price of $29.06, for a total value of $293,941.90. Following the completion of the transaction, the insider now directly owns 451,627 shares in […] ....

New Zealand General , New Zealand , Juliag Butchko , Wolfe Research , Wellington Management Group , Jpmorgan Chase Co , Vanguard Group Inc , Citigroup Inc , Investment Company Inc , Cantor Fitzgerald , Immunovant Inc , Investment Management , Get Free Report , Truist Financial , Management Group , Vanguard Group , Immunovant Daily , Nasdaq Imvt , Insider Trading , Nsider Trades ,

Immunovant, Inc. (NASDAQ:IMVT) Expected to Post Q1 2026 Earnings of ($0.49) Per Share

Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Stock analysts at Zacks Research dropped their Q1 2026 earnings per share (EPS) estimates for Immunovant in a research note issued on Monday, April 8th. Zacks Research analyst E. Bagri now anticipates that the company will post earnings per share of ($0.49) for the quarter, down from their […] ....

United States , Eva Renee Barnett , Peter Salzmann , Immunovant Inc , Cantor Fitzgerald , Securities Exchange Commission , Immunovant Company Profile , Perceptive Advisors , Hermes Inc , Zacks Research , Wolfe Research , Free Report , Get Free Report , Stock Down , Capital Advisors , Renee Barnett , Exchange Commission , Immunovant Daily , Nasdaq Imvt , Earnings Estimates ,

BlackRock MuniVest Fund II, Inc. Announces Monthly Dividend of $0.05 (NYSE:MVT)

BlackRock MuniVest Fund II, Inc. (NYSE:MVT – Get Free Report) announced a monthly dividend on Monday, April 1st, Wall Street Journal reports. Stockholders of record on Monday, April 15th will be paid a dividend of 0.0505 per share by the financial services provider on Wednesday, May 1st. This represents a $0.61 dividend on an annualized […] ....

United States , America Corp , Invesco Ltd , Guggenheim Capital , Dividend History For Blackrock Munivest Fund , Pathstone Holdings , Blackrock Munivest Fund Ii Stock Performance , Blackrock Advisors , Blackrock Munivest Fund Ii Inc , Blackrock Inc It , Institutional Trading Of Blackrock Munivest Fund , Blackrock Munivest Fund , Morgan Stanley , Get Free Report , Wall Street Journal , Rock Munivest Fund , Blackrock Munivest Fund Ii , Nyse Mvt ,